ESC Premium Access

Beneficial effect of aldosterone antagonism on exercise tolerance in heart failure with preserved ejection fraction- SpironolacTone in myocaRdial dysfUnCTion with redUced exeRcisE capacity (STRUCTURE)

Congress Presentation

About the speaker

Professor Wojciech Kosmala

Wroclaw Medical University, Wroclaw (Poland)
3 presentations
1 follower

4 more presentations in this session

State of the art in drug therapy in chronic heart failure.

Speaker: Professor D. van Veldhuisen (Groningen, NL)


Mortality and morbidity in heart failure patients exposed to Digoxin: comprehensive data according to ejection fraction and atrial fibrillation in 41881 patients from the Swedish Heart Failure Registr

Speaker: Doctor G. Savarese (Stockholm, SE)


Risk of long-term mortality associated with diuretic treatment in 17,519 heart failure outpatients was increased with 42% after adjustment for MAGGIC mortality risk predictors

Speaker: Doctor P. Paren (Gothenburg, SE)


Future direction for research in drug therapy.

Speaker: Professor J. Teerlink (San Francisco, US)


Access the full session

Drug therapy in heart failure

Speakers: Professor W. Kosmala, Professor D. van Veldhuisen, Doctor G. Savarese, Doctor P. Paren, Professor J. Teerlink

About the event


ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb